A low incidence of adverse events was observed:

• No eyes lost more than two lines of BVCA-D at 12 months
• No eyes had BCVA-D of worse than 20/40 at 12 months
• No eyes had more than 2.00 D of cylinder induced at 12 months
• No eyes with 20/20 or better BCVA-D pre-op were worse than 20/25 12 months post-op
• No statistically significant change in contrast sensitivity from pre-op to post-op